世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Induced Pluripotent Stem Cells Production Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global Induced Pluripotent Stem Cells (iPSC) Production Market is poised for significant expansion, with projections estimating the market to reach US$ 1.5 billion by 2025 and soaring to US$ 3.... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global Induced Pluripotent Stem Cells (iPSC) Production Market is poised for significant expansion, with projections estimating the market to reach US$ 1.5 billion by 2025 and soaring to US$ 3.12 billion by 2032, reflecting a robust CAGR of 11.03% during the forecast period. This growth trajectory highlights the increasing importance of iPSCs in regenerative medicine, drug discovery, and disease modeling.Market Insights The iPSC production market is witnessing accelerated momentum due to the rapid advancement in biotechnology and cellular research. Induced pluripotent stem cells—adult cells reprogrammed to an embryonic-like state—hold promising potential in developing personalized therapeutic solutions. The demand for iPSCs is gaining traction across pharmaceutical, biotechnology, and academic sectors, primarily due to their role in disease modeling, drug screening, and the creation of patient-specific therapies. Drivers Fueling the Market The market is driven by several key factors: • Rising Prevalence of Chronic Diseases: Increased cases of diabetes, cancer, cardiovascular, and neurodegenerative disorders are fostering demand for innovative cell therapies. • Growing Investment in Stem Cell Research: Government and private funding for stem cell research initiatives are enabling advancements in iPSC technology. • Clinical Application Potential: The ability of iPSCs to generate any cell type positions them as a preferred tool in regenerative medicine and organ repair. • Ethical Acceptance: iPSCs offer a more ethically viable alternative to embryonic stem cells, fueling adoption in research and therapeutic applications. Business Opportunity iPSC-based technologies offer significant commercial prospects, especially in the pharmaceutical and biotechnology industries. These stem cells are increasingly being used to create high-throughput platforms for drug discovery and toxicity screening, providing cost-effective and human-relevant testing models. Moreover, companies are focusing on automation and standardization of production processes to enhance scalability and reproducibility, unlocking new growth avenues. Emerging applications in personalized medicine and genome editing further bolster the market outlook. Startups and established players alike are investing in technologies that allow for the creation of patient-specific iPSCs, enabling customized treatment approaches and preventive healthcare strategies. Impact of COVID-19 The COVID-19 pandemic intensified global interest in innovative research tools, with iPSCs playing a key role in modeling SARS-CoV-2 infections. Research institutes developed iPSC-derived lung and airway cells to study the virus's impact and test potential drugs. However, challenges such as production scalability, high cost, and quality control remain critical hurdles for widespread implementation. Regional Analysis North America is expected to dominate the global iPSC production market, supported by advanced healthcare infrastructure, strong government support, and high R&D activity. Key initiatives from institutions like the National Institutes of Health (NIH) and the California Institute for Regenerative Medicine (CIRM) are accelerating clinical translation of iPSC research. Europe maintains a steady growth outlook, driven by initiatives such as the European Bank for induced pluripotent Stem Cells (EBiSC), which aims to provide high-quality iPSC lines and related services to the research community. Meanwhile, countries in Asia-Pacific, including Japan and South Korea, are emerging as fast-growing markets due to active participation in iPSC clinical trials and supportive regulatory frameworks. Key Players Leading companies operating in the iPSC production space include: • Lonza • Axol Biosciences Ltd. • Evotec • Hitachi Ltd. • Merck KGaA • REPROCELL Inc. • Fate Therapeutics • Thermo Fisher Scientific, Inc. • Applied StemCell Inc. These players are increasingly engaging in strategic collaborations, technology launches, and service expansions to strengthen their market positions. Recent Developments • REPROCELL launched a personalized iPSC generation and preservation service and an associated B2B platform to streamline customer access to stem cell technology. • Ngene Therapeutics Inc. partnered with The New York Stem Cell Foundation to advance gene-editing research in iPSCs. Market Segmentation By Product Type • Instruments/Devices • Automated Platforms • Consumables & Kits • Media • Kits • Others • Services By Process • Manual • Automated By Workflow • Reprogramming • Cell Culture • Cell Characterization/Analysis • Engineering • Others By Application • Drug Development and Discovery • Regenerative Medicine • Toxicology Studies • Others By Region • North America • Latin America • Europe • Asia Pacific • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Induced Pluripotent Stem Cells Production Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2025 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Induced Pluripotent Stem Cells Production Market Outlook, 2019-2032 3.1. Global Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 3.1.1. Key Highlights 3.1.1.1. Instruments/Devices 3.1.1.2. Automated Platforms 3.1.1.3. Consumables & Kits 3.1.1.3.1. Media 3.1.1.3.2. Kits 3.1.1.3.3. Others 3.1.1.4. Services 3.2. Global Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2019-2032 3.2.1. Key Highlights 3.2.1.1. Manual 3.2.1.2. Automated 3.3. Global Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2019-2032 3.3.1. Key Highlights 3.3.1.1. Reprogramming 3.3.1.2. Cell Culture 3.3.1.3. Cell Characterization/Analysis 3.3.1.4. Engineering 3.3.1.5. Others 3.4. Global Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2019-2032 3.4.1. Key Highlights 3.4.1.1. Drug Development and Discovery 3.4.1.2. Regenerative Medicine 3.4.1.3. Toxicology Studies 3.4.1.4. Others 3.5. Global Induced Pluripotent Stem Cells Production Market Outlook, by Region, Value (US$ Bn), 2019-2032 3.5.1. Key Highlights 3.5.1.1. North America 3.5.1.2. Europe 3.5.1.3. Asia Pacific 3.5.1.4. Latin America 3.5.1.5. Middle East & Africa 4. North America Induced Pluripotent Stem Cells Production Market Outlook, 2019-2032 4.1. North America Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 4.1.1. Key Highlights 4.1.1.1. Instruments/Devices 4.1.1.2. Automated Platforms 4.1.1.3. Consumables & Kits 4.1.1.3.1. Media 4.1.1.3.2. Kits 4.1.1.3.3. Others 4.1.1.4. Services 4.2. North America Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2019-2032 4.2.1. Key Highlights 4.2.1.1. Manual 4.2.1.2. Automated 4.3. North America Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2019-2032 4.3.1. Key Highlights 4.3.1.1. Reprogramming 4.3.1.2. Cell Culture 4.3.1.3. Cell Characterization/Analysis 4.3.1.4. Engineering 4.3.1.5. Others 4.4. North America Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2019-2032 4.4.1. Key Highlights 4.4.1.1. Drug Development and Discovery 4.4.1.2. Regenerative Medicine 4.4.1.3. Toxicology Studies 4.4.1.4. Others 4.5. North America Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2019-2032 4.5.1. Key Highlights 4.5.1.1. U.S. Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 4.5.1.2. U.S. Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 4.5.1.3. U.S. Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 4.5.1.4. U.S. Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 4.5.1.5. Canada Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 4.5.1.6. Canada Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 4.5.1.7. Canada Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 4.5.1.8. Canada Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 4.5.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Induced Pluripotent Stem Cells Production Market Outlook, 2019-2032 5.1. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 5.1.1. Key Highlights 5.1.1.1. Instruments/Devices 5.1.1.2. Automated Platforms 5.1.1.3. Consumables & Kits 5.1.1.3.1. Media 5.1.1.3.2. Kits 5.1.1.3.3. Others 5.1.1.4. Services 5.2. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2019-2032 5.2.1. Key Highlights 5.2.1.1. Manual 5.2.1.2. Automated 5.3. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2019-2032 5.3.1. Key Highlights 5.3.1.1. Reprogramming 5.3.1.2. Cell Culture 5.3.1.3. Cell Characterization/Analysis 5.3.1.4. Engineering 5.3.1.5. Others 5.4. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2019-2032 5.4.1. Key Highlights 5.4.1.1. Drug Development and Discovery 5.4.1.2. Regenerative Medicine 5.4.1.3. Toxicology Studies 5.4.1.4. Others 5.5. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2019-2032 5.5.1. Key Highlights 5.5.1.1. Germany Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 5.5.1.2. Germany Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 5.5.1.3. Germany Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 5.5.1.4. Germany Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 5.5.1.5. U.K. Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 5.5.1.6. U.K. Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 5.5.1.7. U.K. Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 5.5.1.8. U.K. Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 5.5.1.9. France Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 5.5.1.10. France Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 5.5.1.11. France Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 5.5.1.12. France Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 5.5.1.13. Italy Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 5.5.1.14. Italy Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 5.5.1.15. Italy Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 5.5.1.16. Italy Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 5.5.1.17. Turkey Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 5.5.1.18. Turkey Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 5.5.1.19. Turkey Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 5.5.1.20. Turkey Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 5.5.1.21. Russia Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 5.5.1.22. Russia Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 5.5.1.23. Russia Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 5.5.1.24. Russia Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 5.5.1.25. Rest of Europe Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 5.5.1.26. Rest of Europe Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 5.5.1.27. Rest of Europe Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 5.5.1.28. Rest of Europe Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 5.5.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, 2019-2032 6.1. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 6.1.1. Key Highlights 6.1.1.1. Instruments/Devices 6.1.1.2. Automated Platforms 6.1.1.3. Consumables & Kits 6.1.1.3.1. Media 6.1.1.3.2. Kits 6.1.1.3.3. Others 6.1.1.4. Services 6.2. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2019-2032 6.2.1. Key Highlights 6.2.1.1. Manual 6.2.1.2. Automated 6.3. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2019-2032 6.3.1. Key Highlights 6.3.1.1. Reprogramming 6.3.1.2. Cell Culture 6.3.1.3. Cell Characterization/Analysis 6.3.1.4. Engineering 6.3.1.5. Others 6.4. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2019-2032 6.4.1. Key Highlights 6.4.1.1. Drug Development and Discovery 6.4.1.2. Regenerative Medicine 6.4.1.3. Toxicology Studies 6.4.1.4. Others 6.5. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2019-2032 6.5.1. Key Highlights 6.5.1.1. China Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 6.5.1.2. China Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 6.5.1.3. China Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 6.5.1.4. China Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 6.5.1.5. Japan Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 6.5.1.6. Japan Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 6.5.1.7. Japan Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 6.5.1.8. Japan Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 6.5.1.9. South Korea Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 6.5.1.10. South Korea Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 6.5.1.11. South Korea Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 6.5.1.12. South Korea Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 6.5.1.13. India Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 6.5.1.14. India Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 6.5.1.15. India Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 6.5.1.16. India Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 6.5.1.17. Southeast Asia Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 6.5.1.18. Southeast Asia Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 6.5.1.19. Southeast Asia Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 6.5.1.20. Southeast Asia Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 6.5.1.21. Rest of Asia Pacific Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 6.5.1.22. Rest of Asia Pacific Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 6.5.1.23. Rest of Asia Pacific Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 6.5.1.24. Rest of Asia Pacific Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 6.5.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Induced Pluripotent Stem Cells Production Market Outlook, 2019-2032 7.1. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 7.1.1. Key Highlights 7.1.1.1. Instruments/Devices 7.1.1.2. Automated Platforms 7.1.1.3. Consumables & Kits 7.1.1.3.1. Media 7.1.1.3.2. Kits 7.1.1.3.3. Others 7.1.1.4. Services 7.2. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2019-2032 7.2.1.1. Manual 7.2.1.2. Automated 7.3. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2019-2032 7.3.1. Key Highlights 7.3.1.1. Reprogramming 7.3.1.2. Cell Culture 7.3.1.3. Cell Characterization/Analysis 7.3.1.4. Engineering 7.3.1.5. Others 7.4. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2019-2032 7.4.1. Key Highlights 7.4.1.1. Drug Development and Discovery 7.4.1.2. Regenerative Medicine 7.4.1.3. Toxicology Studies 7.4.1.4. Others 7.5. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2019-2032 7.5.1. Key Highlights 7.5.1.1. Brazil Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 7.5.1.2. Brazil Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 7.5.1.3. Brazil Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 7.5.1.4. Brazil Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 7.5.1.5. Mexico Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 7.5.1.6. Mexico Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 7.5.1.7. Mexico Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 7.5.1.8. Mexico Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 7.5.1.9. Argentina Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 7.5.1.10. Argentina Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 7.5.1.11. Argentina Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 7.5.1.12. Argentina Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 7.5.1.13. Rest of Latin America Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 7.5.1.14. Rest of Latin America Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 7.5.1.15. Rest of Latin America Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 7.5.1.16. Rest of Latin America Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 7.5.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, 2019-2032 8.1. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 8.1.1. Key Highlights 8.1.1.1. Instruments/Devices 8.1.1.2. Automated Platforms 8.1.1.3. Consumables & Kits 8.1.1.3.1. Media 8.1.1.3.2. Kits 8.1.1.3.3. Others 8.1.1.4. Services 8.2. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2019-2032 8.2.1. Key Highlights 8.2.1.1. Manual 8.2.1.2. Automated 8.3. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2019-2032 8.3.1. Key Highlights 8.3.1.1. Reprogramming 8.3.1.2. Cell Culture 8.3.1.3. Cell Characterization/Analysis 8.3.1.4. Engineering 8.3.1.5. Others 8.4. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2019-2032 8.4.1. Key Highlights 8.4.1.1. Drug Development and Discovery 8.4.1.2. Regenerative Medicine 8.4.1.3. Toxicology Studies 8.4.1.4. Others 8.5. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2019-2032 8.5.1. Key Highlights 8.5.1.1. GCC Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 8.5.1.2. GCC Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 8.5.1.3. GCC Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 8.5.1.4. GCC Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 8.5.1.5. South Africa Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 8.5.1.6. South Africa Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 8.5.1.7. South Africa Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 8.5.1.8. South Africa Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 8.5.1.9. Egypt Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 8.5.1.10. Egypt Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 8.5.1.11. Egypt Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 8.5.1.12. Egypt Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 8.5.1.13. Nigeria Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 8.5.1.14. Nigeria Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 8.5.1.15. Nigeria Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 8.5.1.16. Nigeria Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 8.5.1.17. Rest of Middle East & Africa Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2019-2032 8.5.1.18. Rest of Middle East & Africa Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2019-2032 8.5.1.19. Rest of Middle East & Africa Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2019-2032 8.5.1.20. Rest of Middle East & Africa Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2019-2032 8.5.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. By Workflow vs By Process Heatmap 9.2. Manufacturer vs By Process Heatmap 9.3. Company Market Share Analysis, 2025 9.4. Competitive Dashboard 9.5. Company Profiles 9.5.1. Lonza 9.5.1.1. Company Overview 9.5.1.2. Product Portfolio 9.5.1.3. Financial Overview 9.5.1.4. Business Strategies and Development 9.5.2. Axol Biosciences Ltd. 9.5.2.1. Company Overview 9.5.2.2. Product Portfolio 9.5.2.3. Financial Overview 9.5.2.4. Business Strategies and Development 9.5.3. Evotec 9.5.3.1. Company Overview 9.5.3.2. Product Portfolio 9.5.3.3. Financial Overview 9.5.3.4. Business Strategies and Development 9.5.4. Hitachi Ltd. 9.5.4.1. Company Overview 9.5.4.2. Product Portfolio 9.5.4.3. Financial Overview 9.5.4.4. Business Strategies and Development 9.5.5. Merck KGaA 9.5.5.1. Company Overview 9.5.5.2. Product Portfolio 9.5.5.3. Financial Overview 9.5.5.4. Business Strategies and Development 9.5.6. REPROCELL Inc. 9.5.6.1. Company Overview 9.5.6.2. Product Portfolio 9.5.6.3. Financial Overview 9.5.6.4. Business Strategies and Development 9.5.7. Fate Therapeutic 9.5.7.1. Company Overview 9.5.7.2. Product Portfolio 9.5.7.3. Financial Overview 9.5.7.4. Business Strategies and Development 9.5.8. Thermo Fisher Scientific, Inc. 9.5.8.1. Company Overview 9.5.8.2. Product Portfolio 9.5.8.3. Financial Overview 9.5.8.4. Business Strategies and Development 9.5.9. Applied StemCell Inc. 9.5.9.1. Company Overview 9.5.9.2. Product Portfolio 9.5.9.3. Financial Overview 9.5.9.4. Business Strategies and Development 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Fairfield Market Research社の医薬品・バイオテクノロジー分野での最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
